
Gopa Iyer
@IyerGopa
Followers
298
Following
279
Media
0
Statuses
6
RT @ALLIANCE_org: For #TrialTuesday, .@IyerGopa @MSKCancerCenter leads @ALLIANCE_org trial A031701 to see how well gemcitabine hydrochlori….
0
11
0
RT @ChungHanLee3: Cabozantinib plus Nivolumab shows a 48% objective response rate in a phase II study in non-clear cell RCC. @JCO_ASCO @mot….
ascopubs.org
PURPOSETo assess the efficacy and safety of cabozantinib plus nivolumab in a phase II trial in patients with non–clear-cell renal cell carcinoma (RCC).PATIENTS AND METHODSPatients had advanced...
0
36
0
RT @haberurology: Please join me in welcoming @NimaAlmassi to the urology staff @CleClinicUro. Dr. Almassi is returning back to the GUKI fa….
0
13
0
RT @bbmdmsk: @siadaneshmand @pcvblack @garysteinbergmd @UroDocAsh @BladderCancerUS @gorejohn This remains a real concern as we move attempt….
0
6
0
RT @shilpaonc: Excited to open Neoadjuvant trial of dd Gem-Cis in #MIBC with bladder sparing option for pts with select genetic alterations….
0
9
0